Guidelines on exercise testing and prescription for patients at different stages of Parkinson's disease.
Guidelines
Parkinson’s disease
Physical activity
Training
Treatment
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
21
03
2020
accepted:
26
05
2020
pubmed:
10
6
2020
medline:
3
3
2021
entrez:
10
6
2020
Statut:
ppublish
Résumé
Exercise is highly recommended in patients with Parkinson's disease (PD). Exercise-induced amelioration of motor, non-motor, and drug-induced symptoms are widely known. However, specific guidelines on exercise testing and prescription in PD are lacking. This study reviews the literature on exercise-based approaches to the management of symptoms at each stage of the disease and evaluate: (1) the most suitable clinical exercise testing; (2) training programs based on testing outcomes and PD stage; (3) the effects of exercise on antiparkinsonian drugs and to suggest the most effective exercise-medication combination. A systematic search was conducted using the databases MEDLINE, Google Scholar and, Cochrane Library using "Parkinson's Disease AND Physical therapy", "Training AND Parkinson", "Exercise", "Exercise AND Drug" as key words. In addition, references list from the included articles were searched and cross-checked to identify any further potentially eligible studies. Of a total of 115 records retrieved, 50 (43%) were included. From these, 23 were included under the rubric "exercise testing"; 20 focused on the effectiveness of different types of exercise in PD motor-functional symptoms and neuroprotective effects, throughout disease progression, were included under the rubric "training protocol prescription"; and 7 concern the rubric "interaction between exercise and medication", although none reported consistent results. Despite the lack of standardized parameters for exercise testing and prescription, all studies agree that PD patients should be encouraged to regularly train according to their severity-related limitations and their personalized treatment plan. In this manuscript, specific guidelines for tailored clinical testing and prescription are provided for each stage of PD.
Sections du résumé
BACKGROUND
BACKGROUND
Exercise is highly recommended in patients with Parkinson's disease (PD). Exercise-induced amelioration of motor, non-motor, and drug-induced symptoms are widely known. However, specific guidelines on exercise testing and prescription in PD are lacking.
OBJECTIVE
OBJECTIVE
This study reviews the literature on exercise-based approaches to the management of symptoms at each stage of the disease and evaluate: (1) the most suitable clinical exercise testing; (2) training programs based on testing outcomes and PD stage; (3) the effects of exercise on antiparkinsonian drugs and to suggest the most effective exercise-medication combination.
METHODS
METHODS
A systematic search was conducted using the databases MEDLINE, Google Scholar and, Cochrane Library using "Parkinson's Disease AND Physical therapy", "Training AND Parkinson", "Exercise", "Exercise AND Drug" as key words. In addition, references list from the included articles were searched and cross-checked to identify any further potentially eligible studies.
RESULTS
RESULTS
Of a total of 115 records retrieved, 50 (43%) were included. From these, 23 were included under the rubric "exercise testing"; 20 focused on the effectiveness of different types of exercise in PD motor-functional symptoms and neuroprotective effects, throughout disease progression, were included under the rubric "training protocol prescription"; and 7 concern the rubric "interaction between exercise and medication", although none reported consistent results.
CONCLUSIONS
CONCLUSIONS
Despite the lack of standardized parameters for exercise testing and prescription, all studies agree that PD patients should be encouraged to regularly train according to their severity-related limitations and their personalized treatment plan. In this manuscript, specific guidelines for tailored clinical testing and prescription are provided for each stage of PD.
Identifiants
pubmed: 32514871
doi: 10.1007/s40520-020-01612-1
pii: 10.1007/s40520-020-01612-1
doi:
Substances chimiques
Antiparkinson Agents
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
221-246Commentaires et corrections
Type : CommentIn
Références
Dorsey ER, Elbaz A, Nichols E et al (2018) Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939–953. https://doi.org/10.1016/s1474-4422(18)30295-3
doi: 10.1016/s1474-4422(18)30295-3
Magrinelli F, Picelli A, Tocco P et al (2016) Pathophysiology of motor dysfunction in Parkinson's disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis. https://doi.org/10.1155/2016/9832839
doi: 10.1155/2016/9832839
pubmed: 27366343
pmcid: 4913065
Abbas MM, Xu Z, Tan LCS (2018) Epidemiology of Parkinson's disease-east versus west. Mov Disord Clin Pract 5:14–28. https://doi.org/10.1002/mdc3.12568
doi: 10.1002/mdc3.12568
pubmed: 30363342
Collamati A, Martone AM, Poscia A et al (2016) Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res 28:25–35. https://doi.org/10.1007/s40520-015-0359-7
doi: 10.1007/s40520-015-0359-7
pubmed: 25930085
Hirsch MA, Farley BG (2009) Exercise and neuroplasticity in persons living with Parkinson's disease. Eur J Phys Rehabil Med 45:215–229
pubmed: 19532109
Kim JD, McCarter RJM, Yu BP (1996) Influence of age, exercise, and dietary restriction on oxidative stress in rats. Aging Clin Exp Res 8:123–129. https://doi.org/10.1007/BF03339566
doi: 10.1007/BF03339566
Reuter I, Engelhardt M, Stecker K et al (1999) Therapeutic value of exercise training in Parkinson’s disease. Med Sci Sports Exerc 31:1544–1549
doi: 10.1097/00005768-199911000-00008
Suchowersky O, Gronseth G, Perlmutter J et al (2006) Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66:976–982. https://doi.org/10.1212/01.wnl.0000206363.57955.1b
doi: 10.1212/01.wnl.0000206363.57955.1b
pubmed: 16606908
Kwakkel G, De Goede C, Van Wegen E (2007) Impact of physical therapy for Parkinson's disease: a critical review of the literature. Parkinson Relat D 13:478–487. https://doi.org/10.1016/S1353-8020(08)70053-1
doi: 10.1016/S1353-8020(08)70053-1
Schenkman M, Moore CG, Kohrt WM et al (2018) Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol 75:219–226. https://doi.org/10.1001/jamaneurol.2017.3517
doi: 10.1001/jamaneurol.2017.3517
pubmed: 29228079
Riebe D, Ehrman JK, Liguori JK et al (2018) ACSM’s guidelines for exercise testing and prescription, 10th ed
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–34. https://doi.org/10.1016/j.jclinepi.2009.06.006
doi: 10.1016/j.jclinepi.2009.06.006
pubmed: 19631507
Redecker C, Bilsing A, Csoti I et al (2014) Physiotherapy in Parkinson's disease patients: recommendations for clinical practice. Basal Ganglia 4:35–38. https://doi.org/10.1016/j.baga.2014.03.001
doi: 10.1016/j.baga.2014.03.001
Opara JO, Małecki A, Małecka E et al (2017) Motor assessment in Parkinson's Disease. Ann Agric Environ Med 24(3):441–451. https://doi.org/10.5604/12321966.1232774
doi: 10.5604/12321966.1232774
Gallo PM, Ewing Garber C (2011) A comprehensive approach to exercise prescription for the health fitness professional. ACSMs Health Fit J 15:8–17. https://doi.org/10.1249/fit.0b013e31821eca84
doi: 10.1249/fit.0b013e31821eca84
Rebelo-Marques A, De Sousa Lages A, Andrade R (2018) Aging hallmarks: the benefits of physical exercise. Front Endocrinol 9:258. https://doi.org/10.3389/fendo.2018.00258
doi: 10.3389/fendo.2018.00258
Ellis T, Rochester L (2018) Mobilizing Parkinson's disease: the future of exercise. J Parkinsons Dis 8:S95–S100. https://doi.org/10.3233/JPD-181489
doi: 10.3233/JPD-181489
pubmed: 30584167
pmcid: 6311359
Dos Santos Delabary M, Komeroski IG, Monteiro EP et al (2018) Effects of dance practice on functional mobility, motor symptoms and quality of life in people with Parkinson's disease: a systematic review with meta-analysis. Aging Clin Exp Res 30:727–735. https://doi.org/10.1007/s40520-017-0836-2
doi: 10.1007/s40520-017-0836-2
pubmed: 28980176
Bryant MS, Jackson GR, Hou JG et al (2016) Treadmill exercise tests in persons with Parkinson's disease: responses and disease severity. Aging Clin Exp Res 28:1009–1014. https://doi.org/10.1007/s40520-015-0498-x
doi: 10.1007/s40520-015-0498-x
pubmed: 26590841
Oliveira de Carvalho A, Filho ASS, Murillo-Rodriguez E et al (2018) Physical exercise for Parkinson's disease: clinical and experimental evidence. Clin Pract Epidemiol Ment Health 14:89–98. https://doi.org/10.2174/1745017901814010089
doi: 10.2174/1745017901814010089
pubmed: 29785199
pmcid: 5897963
Noonan V, Dean E (2000) Submaximal exercise testing: clinical application and interpretation. Phys Ther 80:782–807
doi: 10.1093/ptj/80.8.782
Mavrommati F, Collett J, Franssen M et al (2017) Exercise response in Parkinson's disease: insights from a cross-sectional comparison with sedentary controls and a per-protocol analysis of a randomised controlled trial. BMJ Open 7:e017194. https://doi.org/10.1136/bmjopen-2017-017194
doi: 10.1136/bmjopen-2017-017194
pubmed: 29282259
pmcid: 5770916
Penko AL, Barkley JE, Miller Koop M et al (2017) Borg scale is valid for ratings of perceived exertion for individuals with Parkinson’s disease. Int J Exerc Sci 10:76–86
pubmed: 28479949
pmcid: 5213192
Mancini M, Horak FB (2010) The relevance of clinical balance assessment tools to differentiate balance deficits. Eur J Phys Med 46:239–248
Chomiak T, Pereira FV, Hu B (2015) The single-leg-stance test in Parkinson's disease. J Clin Med Res 7:182–185. https://doi.org/10.14740/jocmr1878w
doi: 10.14740/jocmr1878w
pubmed: 25584104
Jacobs JV, Horak FB, Tran VK et al (2006) Multiple balance tests improve the assessment of postural stability in subjects with Parkinson's disease. J Neurol Neurosurg Psychiatry 77:322–326. https://doi.org/10.1136/jnnp.2005.068742
doi: 10.1136/jnnp.2005.068742
pubmed: 16484639
pmcid: 2077684
Brusse KJ, Zimdars S, Zalewski KR et al (2005) Testing functional performance in people with Parkinson disease. Phys Ther 85:134–141
doi: 10.1093/ptj/85.2.134
Bloem BR, Marinus J, Almeida Q et al (2016) Measurement instruments to assess posture, gait, and balance in Parkinson’s disease: critique and recommendations. Mov Disord 31:1342–1355. https://doi.org/10.1002/mds.26572
doi: 10.1002/mds.26572
pubmed: 26945525
Keus S, Munneke M, Graziano M et al (2014) European Physiotherapy Guideline for Parkinson's Disease Developed with twenty European professional associations Development and scientific justification, ParkinsonNet KNGF
White DK, Wagenaar RC, Ellis TD et al (2009) Changes in walking activity and endurance following rehabilitation for people with Parkinson disease. Arch Phys Med Rehabil 90:43–50. https://doi.org/10.1016/j.apmr.2008.06.034
doi: 10.1016/j.apmr.2008.06.034
pubmed: 19154828
Light KE, Behrman AL, Thigpen M et al (1997) The 2-minute walk test: a tool for evaluating walking endurance in clients with Parkinson's disease. Neurol Rep 20:136–139
doi: 10.1097/01253086-199721040-00011
Goodwin VA, Richards SH, Taylor RS et al (2008) The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 23:631–640. https://doi.org/10.1002/mds.21922
doi: 10.1002/mds.21922
pubmed: 18181210
Durmus B, Baysal O, Altinayar S et al (2010) Lower extremity isokinetic muscle strength in patients with Parkinson's disease. J Clin Neurosci 17:893–896. https://doi.org/10.1016/j.jocn.2009.11.014
doi: 10.1016/j.jocn.2009.11.014
pubmed: 20435478
Clael S, Brandao E, Caland L et al (2018) Association of strength and physical functions in people with Parkinson's disease. Neurosci J 2018:8507018. https://doi.org/10.1155/2018/8507018
doi: 10.1155/2018/8507018
pubmed: 30643793
pmcid: 6311277
Frazzitta G, Ferrazzoli D, Maestri R et al (2015) Differences in muscle strength in parkinsonian patients affected on the right and left side. PLoS ONE 10:3. https://doi.org/10.1177/1545968313508474
doi: 10.1177/1545968313508474
Koller W, Kase S (1986) Muscle strength testing in Parkinson's disease. Eur Neurol 25:130–133. https://doi.org/10.1159/000115998
doi: 10.1159/000115998
pubmed: 3948887
Lombara A (2017) Parkinson's disease: an overview. Phys Ther 20:20
Cancela JM, Ayán C, Gutiérrez-Santiago A et al (2012) The Senior fitness test as a functional measure in Parkinson’s disease: a pilot study. Parkinson Relat Disord 18:170–173. https://doi.org/10.1016/j.parkreldis.2011.09.016
doi: 10.1016/j.parkreldis.2011.09.016
Buckley TA, Hass CJ (2012) Reliability in one-repetition maximum performance in people with Parkinson's disease. Parkinsons Dis. https://doi.org/10.1155/2012/928736
doi: 10.1155/2012/928736
pubmed: 22135765
Zoladz JA, Majerczak J, Zeligowska E et al (2014) Moderate-Intensity interval training increases serum brain-derived neurotrophic factor level and decreases inflammation in Parkinson's disease patients. J Physiol Pharmacol 65:441–448
pubmed: 24930517
Harvey M, Weston KL, Gray KG et al (2019) High-intensity interval training in people with Parkinson’s disease: a randomized, controlled feasibility trial. Clin Rehabil 33:428–438. https://doi.org/10.1177/0269215518815221
doi: 10.1177/0269215518815221
pubmed: 30514114
Shulman LM, Katzel LI, Ivey FM et al (2013) Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol 70:183–190. https://doi.org/10.1001/jamaneurol.2013.646
doi: 10.1001/jamaneurol.2013.646
pubmed: 23128427
pmcid: 4574905
Kim Y, Lai B, Mehta T et al (2019) Exercise training guidelines for multiple sclerosis, stroke, and Parkinson disease: rapid review and synthesis. Am J Phys Med Rehabil 98:613–621. https://doi.org/10.1097/PHM.0000000000001174
doi: 10.1097/PHM.0000000000001174
pubmed: 30844920
pmcid: 6586489
Nelson R, Petersen C (2017) The reliability and minimal detectable change of the cardiovascular response and self-selected exercise intensity during forward and backward treadmill exercise in individuals with Parkinson disease. SAGE Open Med. https://doi.org/10.1177/2050312117736229
doi: 10.1177/2050312117736229
pubmed: 29085639
pmcid: 5648080
Speelman AD, Groothuis JT, van Nimwegen M et al (2012) Cardiovascular responses during a submaximal exercise test in patients with Parkinson's disease. J Parkinsons Dis 2:241–247. https://doi.org/10.3233/JPD-2012-012111
doi: 10.3233/JPD-2012-012111
pubmed: 23938232
H. Cianci (2012) A body guide to Parkinson's Disease, Fitness Count
McGraw SM, Hoover DL, Shirey MP (2013) Exercise guidelines for patients with Parkinson’s disease. Home Health Care Manag Pract 26:167–174. https://doi.org/10.1177/1084822313514977
doi: 10.1177/1084822313514977
Nadeau A, Pourcher E, Corbeil P (2014) Effects of 24 wk of treadmill training on gait performance in Parkinson's disease. Med Sci Sports Exerc 46:645–655. https://doi.org/10.1249/MSS.0000000000000144
doi: 10.1249/MSS.0000000000000144
pubmed: 24002341
Salgado S, Williams N, Kotian R (2013) An evidence-based exercise regimen for patients with mild to moderate Parkinson’s disease. Brain Sci 3:87–100. https://doi.org/10.3390/brainsci3010087
doi: 10.3390/brainsci3010087
pubmed: 24961308
pmcid: 4061827
Miyai I, Fujimoto Y, Ueda Y (2000) Treadmill training with body weight support: its effect on Parkinson's disease. Arch Phys Med Rehabil 81:849–852. https://doi.org/10.1053/apmr.2000.4439
doi: 10.1053/apmr.2000.4439
pubmed: 10895994
Hou L, Chen W, Liu X (2017) Exercise-induced neuroprotection of the nigrostriatal dopamine system in Parkinson's disease. Front Aging Neurosci 9:358. https://doi.org/10.3389/fnagi.2017.00358
doi: 10.3389/fnagi.2017.00358
pubmed: 29163139
pmcid: 5675869
Ahlskog JE (2018) Aerobic exercise: evidence for a direct brain effect to slow Parkinson Disease progression. Mayo Clin Proc 93:360–372. https://doi.org/10.1016/j.mayocp.2017.12.015
doi: 10.1016/j.mayocp.2017.12.015
pubmed: 29502566
Frazzitta G, Maestri R, Ghilardi MF (2014) Intensive rehabilitation increases BDNF serum levels in parkinsonian patients: a randomized study. Neurorehabil Neural Repair 28:163–168. https://doi.org/10.1177/1545968313508474
doi: 10.1177/1545968313508474
pubmed: 24213955
Fisher BE, Wu AD, Salem GJ et al (2008) The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's disease. Arch Phys Med Rehabil 89:1221–1229. https://doi.org/10.1016/j.apmr.2008.01.013
doi: 10.1016/j.apmr.2008.01.013
pubmed: 18534554
pmcid: 2989816
Steiger L, Homann CN (2019) Exercise therapy in Parkinson's disease—an overview of current interventional studies. Physiother Res Rep 1:1–10. https://doi.org/10.15761/PRR.1000117
doi: 10.15761/PRR.1000117
Uhrbrand A, Stenager E, Pedersen MS et al (2015) Parkinson's disease and intensive exercise therapy—a systematic review and meta-analysis of randomized controlled trials. J Neurol Sci 353:9–19. https://doi.org/10.1016/j.jns.2015.04.004
doi: 10.1016/j.jns.2015.04.004
pubmed: 25936252
Hirsch MA, Toole T, Maitland CG et al (2003) The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson’s disease11No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors(s) or upon any organization with which the author(s) is/are associated. Arch Phys Med Rehab 84:1109–1117. https://doi.org/10.1016/s0003-9993(03)00046-7
doi: 10.1016/s0003-9993(03)00046-7
EllisT, DeAngelis TR, Dalton D, Venne J (2016) Be active & beyond—a guide to exercise and wellness for people with Parkinson's Disease
Petersen CM, Nelson R, Steffen TM (2013) The effect of Parkinson drug timing on cardiovascular response during treadmill exercise in a person with Parkinson Disease and freezing of gait. Physiother Can 65:217–222. https://doi.org/10.3138/ptc.2011-57
doi: 10.3138/ptc.2011-57
pubmed: 24403689
pmcid: 3740984
Marsden CD, Parkes JD (1977) Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 20:345–349
doi: 10.1016/S0140-6736(77)91146-1
Lopane G, Contin M, Scaglione C et al (2010) The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease. Clin Neuropharmacol 33:254–256. https://doi.org/10.1097/WNF.0b013e3181f5328c
doi: 10.1097/WNF.0b013e3181f5328c
pubmed: 20852413
Reuter I, Harder S, Engelhardt M et al (2000) The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa. Mov Disord 15:862–868. https://doi.org/10.1002/1531-8257(200009)15:5<862:AID-MDS1015>3.0.CO;2-S
doi: 10.1002/1531-8257(200009)15:5<862::AID-MDS1015>3.0.CO;2-S
pubmed: 11009191
Carter JH, Nutt JG, Woodward WR (1992) The effect of exercise on levodopa absorption. Neurology 42:2042–2045. https://doi.org/10.1212/wnl.42.10.2042
doi: 10.1212/wnl.42.10.2042
pubmed: 1407589
Muhlack S, Welnic J, Woitalla D et al (2007) Exercise improves efficacy of levodopa in patients with Parkinson’s disease. Mov Disord 22:427–430. https://doi.org/10.1002/mds.21346
doi: 10.1002/mds.21346
pubmed: 17226855
DiFrancisco-Donoghue J, Elokda A, Lamberg E (2009) Norepinephrine and cardiovascular responses to maximal exercise in Parkinson's disease on and off medication. Mov Disord 24:1773–1778. https://doi.org/10.1002/mds.22612
doi: 10.1002/mds.22612
pubmed: 19562762
Skidmore FM, Patterson SL, Shulman LM et al (2008) Pilot safety and feasibility study of treadmill aerobic exercise in Parkinson disease with gait impairment. J Rehabil Res Dev 45:117–124. https://doi.org/10.1682/JRRD.2006.10.0130
doi: 10.1682/JRRD.2006.10.0130
pubmed: 18566930
Cotman CW, Berchtold NC (2002) Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25:295–301. https://doi.org/10.1016/S0166-2236(02)02143-4
doi: 10.1016/S0166-2236(02)02143-4
pubmed: 12086747
Klemann CJHM, Xicoy H, Poelmans G et al (2018) Physical exercise modulates L-DOPA-regulated molecular pathways in the MPTP mouse model of Parkinson's disease. Mol Neurobiol 55:5639–5657. https://doi.org/10.1007/s12035-017-0775-0
doi: 10.1007/s12035-017-0775-0
pubmed: 29019056
Dibble LE, Lange M (2006) Predicting falls in individuals with Parkinson disease: a reconsideration of clinical balance measures. J Neurol Phys Ther 30:60–67. https://doi.org/10.1097/01.npt.0000282569.70920.dc
doi: 10.1097/01.npt.0000282569.70920.dc
pubmed: 16796770
O’Callaghan A, Harvey M, Houghton D et al (2019) Comparing the influence of exercise intensity on brain-derived neurotrophic factor serum levels in people with Parkinson’s disease: a pilot study. Aging Clin Exp Res. https://doi.org/10.1007/s40520-019-01353-w
doi: 10.1007/s40520-019-01353-w
pubmed: 31606860
Macleod AD, Counsell CE (2010) Timed tests of motor function in Parkinson’s disease. Parkinson Relat Disord 16:442–446. https://doi.org/10.1016/j.parkreldis.2010.04.006
doi: 10.1016/j.parkreldis.2010.04.006
Dibble LE, Foreman KB, Addison O et al (2015) Exercise and medication effects on persons with Parkinson disease across the domains of disability: a randomized clinical trial. J Neurol Phys Ther 39:85–92. https://doi.org/10.1097/NPT.0000000000000086
doi: 10.1097/NPT.0000000000000086
pubmed: 25742370
pmcid: 4366306